Metraipolis › archive › dc_fe6449ebd37a
TNM stage I pancreatic ductal adenocarcinoma patients without pathological risk may drive limited benefit from adjuvant chemotherapy — Europe PMC PMID:42807928
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42807928
- DOI
- 10.3389/fmed.2026.1914610
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T02:32:03.007Z
- SHA-256 of the archived text
8c0427db9cbed78ba35f3519fcf67ee00d45c28ef95cb96f403a3860c63bd7cd- Stable URL of this page
https://metraipolis.com/documento/dc_fe6449ebd37a
How to cite
TNM stage I pancreatic ductal adenocarcinoma patients without pathological risk may drive limited benefit from adjuvant chemotherapy — Europe PMC PMID:42807928 — Europe PMC (en), https://europepmc.org/article/MED/42807928 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe6449ebd37a (Metraipolis archive dc_fe6449ebd37a, sha256 8c0427db9cbed78ba35f3519fcf67ee00d45c28ef95cb96f403a3860c63bd7cd)
BibTeX
@misc{dcfe6449ebd37a,
title = {TNM stage I pancreatic ductal adenocarcinoma patients without pathological risk may drive limited benefit from adjuvant chemotherapy — Europe PMC PMID:42807928},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42807928},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe6449ebd37a; sha256 8c0427db9cbed78ba35f3519fcf67ee00d45c28ef95cb96f403a3860c63bd7cd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42807928. Agents can read the archived copy with the MCP tool read_document.